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Abstract. Higher electromyographic (EMG) activity levels of corrugator and 
zygomatic face muscles have been reported to be pretreatment predictors of better 
clinical outcome in depressed patients. We tested this possibility in 29 drug-free, 
rigorously diagnosed subjects by measuring low-level EMG activity of corrugator 
and zygomatic muscles during resting and three imagery states (happy, typical day, 
sad). All patients had major depressive disorder, endogenous subtype. Good 
responders had significantly higher pretreatment EMG zygomatic values and 
different EMG profiles. Our findings replicate and expand prior reports. 
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Facial expressions are important barometers of psychomotor state in depressed 
patients (Greden and Carroll, 1981). The musculature of the face responds to 
emotional changes with unique speed and sensitivity (Ekman and Friesen, 1975), and 
the facial expressions associated with happiness, sadness, anger, fear, surprise, and 
disgust are believed to be universal (Darwin, 1872; Ekman et al., 1969). The corrugator 
muscles, located on the forehead bilaterally above the bridge of the nose and referred 
to by Darwin (1872) as the “grief muscles,” are considered especially important in 
displays of sadness, mourning, and grief (Ekman and Friesen, 1972). Although facial 
expressions provide visible windows to affective states, their assessment has been 
subjective and error-prone (Whatmore and Ellis, 1975; Ekman and Friesen, 1975; 
Greden and Carroll, 198 1). 
In an attempt to develop an objective, quantifiable monitor for facial activity, 
Schwartz et al. (1975, 1976a, 19766, 1978, 1979, 1980) studied the use of electro- 
myographic (EMG) measures of low-level facial muscle contractions. He and 
colleagues placed surface electrodes upon selected muscle regions of the face and 
recorded EMG activity during self-induced states of affective imagery (e.g.. happy, 
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sad, angry, and “typical day”). A number of muscle regions were studied: (I) 
corrugator (located bilaterally on the forehead above the bridge of the nose); (2) 
zygomatic, the “smile muscle,” located between the angles of the mouth and 
cheekbones bilaterally); and (3) peri-oral muscles such as the depressor anguli oris, 
depressor labii inferioris, and the mentalis (these muscles produce changes in mouth 
expressions during affective fluctuations). Using their EMG approach, Schwartz et al. 
found diagnostic differences between depressives and normals. Each discrete imagery 
task produced a distinct EMG profile (Schwartz et al., 1976a, 1976b), and depressed 
patients differed from nondepressed controls on the basis of their profiles. These 
results have been replicated by other investigational teams (Teasdale and Bancroft, 
1977; Oliveau and Willmuth, 1979; Greden et al., in press). 
Perhaps of greater interest than possible diagnostic differences, Schwartz et al. 
(1978) reported that higher baseline corrugator EMG activity seemed to predict better 
clinical outcome in their depressed patients. Specifically, they noted that those 
subjects with the highest initial corrugator levels showed the greatest clinical 
improvement regardless of treatment selected (amitriptyline or placebo). Laboratory 
predictors of treatment response are such potentially powerful tools (consider the 
benefits of bacteria1 culture and sensitivity testing for selecting antibiotics in patients 
with infectious diseases) that attempts at replication were predictable. Carney et al. 
(198 1) confirmed that subjects with higher initial corrugator EMG levels had greater 
changes in depressive symptoms, and suggested that resting zygomatic EMG scores 
also predicted good outcome. 
These studies on prediction of outcome were pilot assessments and subject to 
expected methodological shortcomings. Specifically, Schwartz and colleagues 
studied: (1) only outpatients; (2) the investigations were not conducted under fully 
“blind” conditions; (3) they required only an unstructured clinical diagnosis of 
depression and a Zung score above 56 as their inclusion criteria; (4) they studied only 
the corrugator at rest; (5) they treated patients with relatively low doses of 
amitriptyline (75-l 50 mg) with no monitoring of plasma levels; and (6) they combined 
a sample of 5 males and 14 females, later reported by the same group to have different 
facial EMG responses (Schwartz et al., 1980). Carney et al. (198 1) studied only female 
inpatients with significant unipolar depression (Beck depression scores above 20), and 
studied three left-sided muscle regions; however, 17 or their 21 subjects had been 
receiving tricyclic antidepressants before study. Both studies also were limited to one 
followup assessment at 2 weeks, and both emphasized changes in rating scale scores as 
dependent variables of improvement, thus introducing possible contamination due to 
Wilder’s (1957) law of initial values (subjects with higher levels at one time point will 
show greater decreases at a second time point). Schwartz et al. (1978) stated: “Until the 
specific finding for resting corrugator activity is replicated on a larger sample with 
full-blind conditions, it must be seen as tentative.” We agreed, and sought to control 
for methodological issues mentioned above. After doing so, we replicated and 




Subjects, Setting, and Outcome Criteria. We studied 29 right-handed, female, 
nondelusional patients. Each was hospitalized in the Clinical Studies Unit (CSU) for Affective 
Disorders, a 12-bed unit at the University of Michigan Hospital. Each patient was drug-free for 
IO-14 days before EMG testing. Our evaluation procedure has been described in detail 
elsewhere (Greden et al., 1980). In summary, each patient underwent a detailed assessment after 
drug washout. The assessment included two independent clinical and structured interviews 
(Schedule for Affective Disorders and Schizophrenia; SADS) (Spitzer and Endicott, 1975) and 
thorough medical screening. Treatments were selected for clinical efficacy. All subjects were 
treated with imipramine, desipramine, amitriptyline, or maprotoline. Plasma concentrations 
were documented to be in the therapeutic range (> 180 ng/ ml) for 27 of the 29 patients. Two 
individuals received maprotoline in an accepted dose range, but had no plasma assays (both 
were good responders). All diagnoses and treatment selections were formulated by diag- 
nosticians unaware of EMG results, Raters without knowledge of EMG data completed the 
17-item Hamilton Rating Scale for Depression (HRSD) (Hamilton, 1960) on a weekly basis. 
Go&responders were defined before data analysis as patients with at least a 50% decrease in 
HRSD scores and a final HRSD score of less than IO (to account for the law of initial values). 
Poor responders were patients with one or neither of these two criteria. 
As shown in Table I, good responders and poor responders did not differ significantly in age, 
pretreatment severity, diagnostic subtype (unipolar vs. bipolar), postdexamethasone plasma 
cortisol concentration, or length of treatment. Because of our outcome criteria, the two 
subgroups showed predictable posttreatment differences at time of hospital discharge in total 
HRSD scores, Carroll Depression Scale scores, degree of psychomotor retardation, and 
maximum postdexamethasone plasma cortisol concentrations. 
EMG Techniques. Our EMG procedure, adapted from techniques developed by Schwartz et 
al., was similar for each subject studied. All patients were asked to complete a questionnaire to 
determine handedness. EMGs were conducted between 9 and I1 a.m. to control for possible 
chronobiological factors. Beckman miniature Ag/ AgCl electrodes were placed bilaterally over 
the regions of the corrugator and zygomatic muscles, Before electrodes were attached, all skin 
locations were gently abraded with alcohol pads until a slight redness appeared. Placement 
procedures were standardized for each muscle region. To distract attention from the study’s 
objectives, we used “dummy” electrodes on both wrists, both forearms over the region of the 
flexor muscles, and below the left clavicle. 
To reduce static charge effects, we placed a single ground connection to the nape of the neck. 
The low level DC bioelectric potential was amplified, full-wave rectified, and integrated by a 
Grass Instruments wide band AC preamplifier and integrator (Model 7P3A). This signal was 
then further amplified by a Grass DC driver amplifier (Model 7DAB). All signals were 
integrated over a time constant of 500 ms. 
Within each session, we stored data collection “runs” for resting (baseline) levels and three 
imagery states (happy, typical day, and sad). To generate these imagery states, we asked subjects 
to sit as quietly as possible with eyes closed. We then instructed them: “During this procedure, 
you will be asked to think about several types of situations. Do the best you can with each of 
these instructions without actually talking to me. You do not need to tell me what you are 
thinking. Please try to continue to think about the particular situation until you hear me say to 
relax.” 
The specific instructions for the various self-generated stimuli were: “Now 1 want you to think 
about a particular situation which made you feel [e.g., happy, sad]. While you are 
thinking about it. please try to reexperience the feeling you had at that time.” Instructions for 
the typical day imagery were further amplified by telling subjects that we wanted them to think 
sequentially about what they did throughout a typical day until they went to sleep. 
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Table 1. Comparison of demographic and clinical variables in endogenous 




h = 201 In = 9) t D 
Age 56.07 + 18.49 
Total 17-item HRSD imean ?I SD) 
Pretreatment 
Discharge 
Total Carroll depression score 
(mean k SDi 
Pretreatment 
Discharge 
Selected Hamilton Scale items 





Dexamethasone suppression test (DSTI results 
(mean k SDI 
Pretreatment maximum postdexamethasone 
plasma cortisol cpg/dl I 
Posttreatment maximum post 
dexamethasone plasma cortisol ipg/dll 
Pretreatment number of DST 
nonsuppressors i%i 
22.55 2 5.79 
3.60 f 2.66 
33.40 k 7.30 30.75 t 9.35 0.80 -0.43 
9.73 2 6.08 25.25 k 11.64 -4.57 0.0011 
0.95 IL 1.14 0.75 -t 0.88 0.44 0.66 
0.22 k 0.41 0.62 + 0.84 -1.55 0.13 
1.20 IL 0.83 1.38 2 0.91 -0.49 0.62 
0.06 k 0.25 1 .oo 2 1.04 -3.64 0 .OOll 
10.33 k 8.77 
3.99 i- 4.64 
14 170%1 





6 I 30% 1 
14 
6 
53.89 2 13.60 0.31 0.76 
21.12 k 4.61 0.62 0.54 
17.25 -t 8.72 -6.44 0.0011 
10.66 i 8.94 -0.90 0.93 
9.37 +- 8.42 -2.05 0.05’ 
5 / 56% I 9 = 0.112 
df= 1 
p = 0.74 
5 (56% x2 = 0.81 
df= 1 
p = 0.37 
6 
3 
x2 = 0.06 
df= 1 
p = 0.37 
1. Statistically signlflcant difference 
Data Analysis. We log-transformed EMG values before statistical analysis to obtain 
normality of distribution (Gaddum, 1945). We then compared EMG values for good and poor 
responders using a 2 x 4 repeated measures analysis of variance (ANOVA). The factors used 
were groups (good and poor responders) and conditions (baseline, happy, typical day, and sad). 
The x’ test or Fisher’s Exact Probability Test was used to compare nonparametric variables. 
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Results 
Group means and standard deviations for each muscle region and condition are 
presented in Table 2. Fig. I depicts pretreatment mean EMG activity values, and 
compares good and poor responders. 
Table 2. Comparison of EMG values in microvolts in left corrugator and left 
zygomatic regions between good responders and poor responders1 
Patients with major depressive Student’s 
disorder, endogenous subtype two-sample 
Good responders Poor responders t test 
(n = 201 (n = 91 t D 
Left corrugator 
Baseline 3.17 k 0.96 
Happy 3.37 + 0.95 
Typical day 3.39 + 0.90 
Sad 3.63 t 0.95 
Left zygomatic 
Baseline 2.81 f 0.65 
Happy 2.89 + 0.59 
Typical day 2.83 2 0.58 
Sad 2.89 + 0.64 
1. Results are presented as mean f SD. 
2. Statistically significant difference. 
3.17 k 0.75 -0.02 0.99 
3.09 f 0.84 0.73 0.47 
3.11 k 0.77 0.79 0.43 
3.43 + 0.63 0.56 0.57 
2.37 f 0.37 1.85 0.07 
2.35 k 0.34 2.43 0.022 
2.37 i 0.39 2.13 0.042 
2.49 f 0.40 2.48 0.10 
To analyze facial muscle patterns and group differences, we conducted a 2 x 4 
repeated measures ANOVA (group as the between factor and condition as the within 
factor) for the zygomatic and corrugator muscle regions. For the zygomatic region, we 
found a significant main effect for group (F= 5.09; alf= 1,27;p < 0.05). EMG activity 
for the good responders was generally higher across conditions than that for the poor 
responders. No main effect for condition was found (F= 2.07; df = 3, 81; p > 0.05), 
indicating similar EMG activity across conditions within each group. No group x 
condition interaction was found (F = 0.78; df= 3, 81; p > 0.05). 
We then conducted a repeated measures ANOVA for the corrugator muscle region. 
In contrast to the zygomatic region, no significant main effect was found for group (F 
= 0.30; df= 1,27;p > 0.05). A significant main effect for condition was noted (F= 5.99; 
df= 3,81;p<O.O01). No group x condition interaction was found (F= 1.02; df=3,8l;p 
> 0.05). Thus, although no significant group differences were found between good and 
poor responders in the corrugator region, the condition main effect suggests that both 
good and poor responders have greater EMG activity for sad imagery than for happy 
and typical day imagery. Differences across the three imagery states are illustrated in 
Fig. 1. 
Discussion 
These data support prior findings (Schwartz et al., 1978; Carney et al., 1981) that 
pretreatment facial EMG values may predict treatment outcome in endogenous 
depressives treated with antidepressants. 
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Fig. 1. Pretreatment electromyographic (EMG) activity levels during baseline 
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l Endogenous AEndogenous 
Good Responders Poor Responders 
Patients In = 291 all had major depresswe disorder, endogenous subtype. Solid circles show log-transformed 
EMGvaluesforgoodrespondersin=20],andopentrianglesshowvaluesforpoorresponders~n=9!.Asterisks 
reveal significant differences based on Student’s two-sample t test. 
It is not surprising that an electrophysiological measure of psychomotor state might 
be linked to treatment response because the psychomotor variables of agitation and 
retardation have historically been considered important clinical predictors of 
treatment outcome (Overall et al., 1966; Paykel, 1972; Paykel et al., 1973; Kupfer and 
Spiker, 1981). Possible explanations for the ability of pretreatment EMG activity to 
predict clinical outcome include the following: 
1. EMG values might reflect heterogeneity among endogenous depressives, with 
differing subgroups having differing outcomes. For example, if one subgroup of 
depressives had increased psychophysiological “arousal” and consequently increased 
EMG levels, and if, moreover, the central nervous system (CNS) pathophysiology 
producing such arousal was responsive to antidepressants, then increased EMG levels 
might predict better response. Conversely, a different subgroup might have CNS 
psychophysiological “blunting,” and the pathophysiology underlying this state might 
be unresponsive or less responsive to traditional antidepressants. These prospects 
have credibility, since close associations between CNS activity and facial expressions 
have been demonstrated, with voluntary creation of facial prototypes of emotion 
having been shown to generate immediate emotion-specific activity in the autonomic 
nervous system (Ekman et al., 1983). 
2. EMG values might covary with other factors that influence outcome, such as 
chronicity, age, severity, or presence of delusions. In our study, we found little support 
for age, severity, or delusions accounting for differences, since good responders and 
poor responders had no pretreatment differences for age or severity, and we excluded 
delusional subjects. Chronicity will require further study. 
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3. Patients with increased EMG activity (the good responders) might be more 
“reactive” to the laboratory situation (Schwartz et al., 1978) and the imagery stimuli. 
Such increased reactivity could be associated with better outcome. This viewpoint is 
neither supported by prior studies (Schwartz et al., 1978; Carney et al., 1981), since 
significant differences have been found for baseline values, nor by our study, in which 
zygomatic baseline differences between good and poor responders approached 
significance (p q 0.07). Nevertheless, the issue requires further evaluation. 
4. Patients with low EMG values might have a different etiology of their depressive 
symptoms-one conceivably associated with a poorer response to antidepressants. 
For example, could patients with low EMG levels have a pituitary microadenoma with 
unrecognized Cushing’s syndrome and associated depression? Or some other patho- 
physiologic process not responsive to antidepressant medications? 
More replications of these data in studies using broader patient samples are 
required. Because of our intentional sampling restrictions, we cannot generalize our 
findings to males, left-handed individuals, or delusional depressives. Studies with 
electroconvulsive treatments would also be informative to generalize to different 
treatment modalities. If findings remain robust, attention then can be focused on the 
search for pathophysiologic and/ or treatment differences between good responders 
and poor responders. Clinically, more intense serial monitoring of “high-risk” subjects 
(those not predicted to have good outcome) could be conducted during treatment, 
other etiologies could be sought, and treatment adequacy could be monitored and 
modified if necessary. The ultimate aim would be to identify more specific or effective 
treatment approaches for patients who currently respond poorly. Thus, facial EMGs 
conceivably could be integrated with serial monitoring (Kupfer and Spiker, 1981) to 
produce improved treatment, the sine qua non of any good laboratory test. 
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